Heme as an initial treatment for severe decompensation in tyrosinemia type 1

Genet Med. 2020 Feb;22(2):437-438. doi: 10.1038/s41436-019-0658-z. Epub 2019 Oct 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Amino Acid Metabolism, Inborn Errors*
  • Canada
  • Consensus
  • Heme
  • Humans
  • Tyrosinemias*

Substances

  • Heme